About this episode
The episode discusses the resurgence of cannabis ETFs, focusing on the AdvisorShares Pure US Cannabis ETF and its potential impact on the market.
A long-dormant trade is suddenly showing signs of life. Prices are climbing. Volumes are spiking. And in a corner of the market that’s spent years in the doldrums, one ETF is catching a fresh buzz — thanks in part to the US Justice Department’s move in April to reclassify medical marijuana as a less dangerous drug. On this episode of Trillions, Eric Balchunas and Joel Weber debut a new monthly segment spotlighting an ETF that’s having a moment. This time, Bloomberg Intelligence’s Andre Yapp joins to break down the AdvisorShares Pure US Cannabis ETF (MSOS). The only cannabis-focused ETF with more than $1 billion in assets, it uses swaps to access marijuana companies just as shifting tax rules begin to ease the industry’s burden. The setup looks promising—but is this a real turning point, or just another short-lived high? See omnystudio.com/listener for privacy information.
People in this episode
Hosts: Eric Balchunas, Joel Weber
Guest: Andre Yapp
Topics covered
- cannabis
- ETF
- investing
- market trends
- medical marijuana
Keywords
- cannabis ETF
- AdvisorShares
- market trends
- medical marijuana
- investing
Mentioned in this episode
Organizations: US Justice Department, Bloomberg Intelligence
Products: AdvisorShares Pure US Cannabis ETF
More episodes of Trillions
- ETF of the Moment: Software Isn't Dead, Yet · June 11, 2026 · 13 min
- The Biggest IPO Ever Meets Passive Investing · June 4, 2026 · 25 min
- New ETFs to Watch: POETs, HALOs and Corgis · May 28, 2026 · 16 min
- The Big Long: Risk and Reward With Ben Carlson · May 21, 2026 · 32 min
- How to Invest During a Trump Presidency · May 7, 2026 · 22 min
- ETFs to Watch From Morgan Stanley, Vanguard and ... Pzena? · April 30, 2026 · 11 min
Explore listener stats, chart rankings, contacts and more on the Trillions podcast page.